AVE Science & Technology Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.029x

AVE Science & Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, AVE Science & Technology Co Ltd (688067) has a cash flow conversion efficiency ratio of 0.029x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.02 Million ≈ $2.20 Million USD) by net assets (CN¥518.37 Million ≈ $75.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of AVE Science & Technology Co Ltd (2012–2024)

Cash flow conversion efficiency of AVE Science & Technology Co Ltd from 2012 to 2024. This chart illustrates how AVE Science & Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688067 stock price and chart for real-time trading data and today's change.

AVE Science & Technology Co Ltd Cash Flow Conversion Ratio Explained

AVE Science & Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

AVE Science & Technology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AVE Science & Technology Co Ltd ranked by their cash flow conversion efficiency. Also see AVE Science & Technology Co Ltd (688067) total market value for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
XANO Industri AB (publ)
ST:XANO-B
-0.006x
Hold-Key Electric Wire & Cable Co Ltd
TW:1618
-0.033x
QDRO Acquisition Corp. Class A Ordinary Shares
NASDAQ:QADR
-0.001x
CEA Industries Inc.
NASDAQ:BNC
0.018x
Amtech Systems Inc
NASDAQ:ASYS
0.010x
TriSalus Life Sciences Inc.
NASDAQ:TLSI
-2.536x
Precision BioSciences Inc
NASDAQ:DTIL
-0.297x
Telecomunicações Brasileiras S.A. - TELEBRÁS
SA:TELB3
-0.032x

Annual Cash Flow Conversion Efficiency for AVE Science & Technology Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of AVE Science & Technology Co Ltd from 2012 to 2024. Review 688067 cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥495.85 Million
≈ $72.56 Million
CN¥22.41 Million
≈ $3.28 Million
0.045x -2.60%
2023-12-31 CN¥489.84 Million
≈ $71.68 Million
CN¥22.73 Million
≈ $3.33 Million
0.046x -25.87%
2022-12-31 CN¥475.12 Million
≈ $69.52 Million
CN¥29.74 Million
≈ $4.35 Million
0.063x -36.65%
2021-12-31 CN¥477.58 Million
≈ $69.88 Million
CN¥47.19 Million
≈ $6.90 Million
0.099x -50.17%
2020-12-31 CN¥236.72 Million
≈ $34.64 Million
CN¥46.93 Million
≈ $6.87 Million
0.198x -19.38%
2019-12-31 CN¥252.51 Million
≈ $36.95 Million
CN¥62.10 Million
≈ $9.09 Million
0.246x +32.38%
2018-12-31 CN¥217.27 Million
≈ $31.79 Million
CN¥40.36 Million
≈ $5.91 Million
0.186x +42.49%
2017-12-31 CN¥189.95 Million
≈ $27.80 Million
CN¥24.76 Million
≈ $3.62 Million
0.130x -25.67%
2016-12-31 CN¥177.84 Million
≈ $26.02 Million
CN¥31.19 Million
≈ $4.56 Million
0.175x +21.23%
2015-12-31 CN¥147.53 Million
≈ $21.59 Million
CN¥21.35 Million
≈ $3.12 Million
0.145x -14.61%
2014-12-31 CN¥138.28 Million
≈ $20.24 Million
CN¥23.43 Million
≈ $3.43 Million
0.169x +38.06%
2013-12-31 CN¥121.15 Million
≈ $17.73 Million
CN¥14.87 Million
≈ $2.18 Million
0.123x -6.50%
2012-12-31 CN¥103.11 Million
≈ $15.09 Million
CN¥13.53 Million
≈ $1.98 Million
0.131x --

About AVE Science & Technology Co Ltd

SHG:688067 China Medical Instruments & Supplies
Market Cap
$200.20 Million
CN¥1.37 Billion CNY
Market Cap Rank
#16297 Global
#4617 in China
Share Price
CN¥20.12
Change (1 day)
-3.22%
52-Week Range
CN¥18.15 - CN¥29.63
All Time High
CN¥37.29
About

AVE Science&Technology CO.,LTD researches, develops, manufactures, markets, and services medical devices, biological reagents, remote medical diagnosis network, computer software, automatic control devices, and medical auxiliary equipment China, Europe, the United States, Asia, Africa, and internationally. The company offers urine formed elements analyzer and related reagents, automatic urine ana… Read more